Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : AMLN (DIABETES DRUGS) -- Ignore unavailable to you. Want to Upgrade?

To: Henry Niman who wrote (1196)	3/5/1998 1:07:00 AM
From: The Gambler	Read Replies (1) \| Respond to of 2173

>>My comments are based on the published Phase III results coupled with advances by others in the oral treatment area.<< Henry, your response did not answer my question whether AMLN chances for success with it's type II diabetes are minimal based on reported findings or other reasons that you maybe understand better than a regular guy like me. Advances by others in this context has no effect whatsoever that will minimized the chances for AMLN to succeed in their research. Sorry, this time I disagree with you.